ANGPTL2 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: We also demonstrated that Angptl2‐deficient tRCC cells show enhanced intracellular MHC‐I antigen processing, leading to accelerated CD8+ T‐cell activation and tumor cell eradication.